Hoʻokaʻawale ʻia ka pollution ea waho a me ka particulate matter (PM) ma ke ʻano he carcinogens kanaka pūʻulu 1 no ka maʻi kanesa o ka maʻi. ʻO nā hui haumia me nā maʻi maʻi hematologic he manaʻo maikaʻi, akā ʻo kēia mau maʻi maʻi maʻi he aetiologically heterogeneous a nele nā hoʻokolohua sub-type.
Nā ʻano hana
Ua hoʻohana ʻia ka American Cancer Society Cancer Prevention Study-II Nutrition Cohort e nānā i nā hui o nā mea haumia o waho me nā maʻi maʻi hematologic makua. Ua hoʻonohonoho ʻia nā wānana makahiki o ka ʻāpana ʻāpana (PM2.5, PM10, PM10-2.5), nitrogen dioxide (NO2), ozone (O3), sulfur dioxide (SO2), a me carbon monoxide (CO) me nā helu noho. Ua manaʻo ʻia nā lākiō pōʻino (HR) a me 95% hilinaʻi (CI) ma waena o nā mea haumia manawa like ʻole a me nā ʻano haematologic.
Nā hualoaʻa
Ma waena o 108,002 mau mea komo, 2659 mau maʻi maʻi hematologic i ʻike ʻia mai 1992-2017. ʻO nā kiʻekiʻe kiʻekiʻe o ka PM10-2.5 i pili me ka lymphoma cell mantle (HR no 4.1 μg / m3 = 1.43, 95% CI 1.08-1.90). Ua pili ka NO2 me Hodgkin lymphoma (HR no 7.2 ppb = 1.39; 95% CI 1.01-1.92) a me ka lymphoma zone marginal (HR no 7.2 ppb = 1.30; 95% CI 1.01-1.67). Ua pili ka CO me ka palena palena (HR no 0.21 ppm = 1.30; 95% CI 1.04-1.62) a me T-cell (HR no 0.21 ppm = 1.27; 95% CI 1.00-1.61) lymphomas.
Nā hopena
ʻO ke kuleana o nā mea haumia ea ma luna o nā maʻi maʻi hematologic paha ua hoʻohaʻahaʻa mua ʻia ma muli o ke ʻano heterogeneity sub-type.
Pono mākou i ka ea maʻemaʻe e hanu ai, a ʻo ka hapa nui o nā noi e koi i nā ʻano ea kūpono e hana pono ai, no laila he mea nui e makaʻala i ko mākou puni. Ma kēia ʻano, hāʻawi mākou i kahi ʻano o nā mea ʻike kaiapuni e ʻike i nā mea e like me ka ozone, carbon dioxide a me nā mea hoʻohuihui kūlohelohe (VOC).
Ka manawa hoʻouna: Mei-29-2024